Skip to main content
. 2019 Sep 10;10(52):5439–5453. doi: 10.18632/oncotarget.27145

Figure 2. Associations between PSA immunostaining results (using the anti PSA antibody at 1:100 and 1:800 dilution), TMPRSS2: ERG fusion status and PTEN deletion status.

Figure 2

(A) PSA immunostaining scored for presence or absence of apical predominance. (B) PSA immunostaining scored for the staining intensity.